3 Amendment of regulation 48
In regulation 48(2) (definitions in relation to the Part on marketing authorisations), after the definition of “generic medicinal product” insert—

““parallel import licence” means a licence that—
(a) is granted by the licensing authority in compliance with the rules of European Union Law relating to parallel imports; and
(b) authorises the holder to place on the market a medicinal product imported into the United Kingdom from another EEA State;”

.